Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 5/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.48 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.48 |
| ▸ | TP53 | P04637 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | CYP2C8 | P10632 | 1/20 | 0.37 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2294325 | 0.90 | CYP2C9 (0.53) | CYP2C9CYP3A4CYP2C19KCNH2 | |
| SCHEMBL2298808 | 0.90 | CYP2C9 (0.59) | CYP2C9CYP3A4CYP2C19KCNH2 | |
| SCHEMBL6119827 | 0.90 | CYP2C9 (0.51) | CYP2C9CYP3A4CYP2C19KCNH2 | |
| SCHEMBL6119825 | 0.88 | CYP2C9 (0.49) | CYP2C9CYP3A4CYP2C19KCNH2 | |
| SCHEMBL6119471 | 0.87 | CYP2C9 (0.51) | CYP2C9CYP3A4CYP2C19KCNH2 | |
| SCHEMBL2300601 | 0.85 | CYP2C9 (0.54) | CYP2C9CYP3A4CYP2C19KCNH2 | |
| SCHEMBL2296799 | 0.82 | CYP2C9 (0.43) | CYP2C9CYP3A4CYP2C19KCNH2 | |
| SCHEMBL2295568 | 0.82 | CYP2C9 (0.48) | CYP2C9CYP3A4CYP2C19KCNH2 | |
| SCHEMBL6119844 | 0.82 | CYP2C9 (0.50) | CYP2C9CYP3A4CYP2C19KCNH2 | |
| SCHEMBL6120266 | 0.82 | CYP2C9 (0.41) | CYP2C9CYP3A4CYP2C19KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011103063-A1 | THERAPEUTIC COMPOUNDS | GLAXO GROUP LIMITED (GB) | 2011-08-25 | — | — | WO | disclosed |